[Atrial fibrillation due to non-valvular causes: indications for antithrombotic therapy].
Codinach Huix
P
P
Servicio de Cardiología, Hospital de la Cruz Roja, Barcelona.
D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000209:etiology*; D002561:Cerebrovascular Disorders / Q000517:prevention & control; D002986:Clinical Trials as Topic; D004617:Embolism / Q000517:prevention & control; D005343:Fibrinolytic Agents; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012307:Risk Factors; D014859:Warfarin / Q000627:therapeutic use*
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin; D001241:Aspirin
Fibrilación auricular de causa no valvular: indicaciones de terapia antitrombótica.